Welcome to Targeting Phage Therapy

Phage2024SliderSessions

The 7th World Conference on Targeting Phage Therapy is being organized on June 20-21, 2024 at Corinthia Palace Malta.

We invite you to the Phage Therapy 2024 Conference, a two-day event focused on the latest in phage research, current challenges, and future directions. This conference will bring together experts, researchers, and healthcare professionals to discuss phage therapy and its application in medicine.

Keynote Speech 2024: Prof. Robert T. Schooley

It is a great pleasure to welcome Prof. Robert Schooley, from University of California, San Diego (USA) as a key note speaker during Targeting Phage Therapy 2024, this June in Malta.
 
He will present a talk on: Phage Therapy: From Biological Mechanisms to Future Directions.

Save the Dates

Among the speakers

Phage Therapeutics 2024: The Critical Role of Translational Research in Clinical Trials

Robert T. Schooley

University of California, San Diego, USA

Phage Therapy: A Glimpse into Clinical Studies Involving Over 150 Cases

Nannan Wu

Shanghai Public Health Clinical Center, Fudan University, China

Mycobacteriophages and Their Therapeutic Potential

Graham F. Hatfull

University of Pittsburgh, USA

The Phageome in Normal and Inflamed Human Skin

Wolfgang Weninger

Medical University of Vienna, Austria

Evolution and megataxonomy of viruses: the place of phages in the virosphere

Eugene V Koonin

National Institutes of Health, USA

Targeting Phage Therapy 2023: Concluding Remarks & What’s Next

The 6th World Congress on Targeting Phage Therapy 2023  was successfully held on June 1-2, 2023 in Paris. It gathered more than 150 attendees from 30+ different countries, and included 71+ communications. Targeting Phage Therapy 2023 discussed all aspects related to phages and phage therapy. 

Who Attended Targeting Phage Therapy 2023?

Industrial participants:

PHIOGEN (USA)
Armata Pharmaceuticals (USA)

BiomX (Israel)
Acteryon (Poland)
Cellexus (UK)
Adaptive Phage Therapeutics (USA)
Aparon (UK)
AusHealth (Australia)
Biochimpharm JSC (Georgia)
BIOCODEX (Paris)
BIOMERIEUX SA (France)
COBIK (Slovenia)
ERYTECH Pharma (France)
H Venture Partners (USA)
H Ventures (USA)
Intralytix, Inc. (USA)
Jafral (Slovenia)
MB Pharma s.r.o. (Czech Republic)
Microbiotix Inc. (USA)
Optipharm Inc. (Republic of Korea)
Phage Consulting
Phages2Patients (Germany)
Phagos (France)
Pherecydes Pharma (France)
Proteon Pharmaceuticals S.A. (Poland)
R.E.D. Laboratories (Belgium)
Resistell (Switzerland)
Rime Bioinformatics (France)
Sanofi (USA)
SET Medikal (Turkey)
TechnoPhage (Poland)
Tillotts Pharma AG (Switzerland)
Vésale Bioscience (Belgium)
Vetoquinol (France)
Vitalis Phage Therapy (India)

Academic participants:

Adam Mickiewicz University, Agricultural University of Athens, Amrita Universit, Armata Therapeutics, Azabu University, Bacteriophage.news, Baylor College of Medicine, Bhabha Atomic Research Centre, Biological Research Centre, Szeged, Campus Universitaire de Maubeuge, Centre International de Recherche en Infectiologie, Chungnam Natl. Univ., Comenius University, Communicable Diseases Institute, Consejo Superior de Investigaciones Científicas, Corpo De Bombeiros Militar Do Amazonas,Corpo De Bombeiros Militar Do Amazonas / Fundação Universidade Aberta Da Terceira Idade, CY Paris Cergy Université, Department of Veterinary Medicine, Institute of Pharmacology and Toxicology, Free University Berlin, Deutsches Zentrum für Infektionsforschung, ENS de Lyon, Eötvös Loránd University, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Food and Drug Administration (FDA), Fundação Universidade Aberta Da Terceira, Fundación AZTI, G. Eliava Institute of Bacteriophages, microbiology and virology ,Geneva University Hospital, German Center for Infection Research (DZIF),German Federal Institute for Risk Assessment, Helmholtz Center Munich, Hirszfeld Institute of Immunology and Experimental Therapy, Hôpitaux Unversitaires de Genève,Hospices Civils de Lyon, Ilia State University, INSERM, Institut Pasteur, Instituto de Biología Integrativa de Sistemas (I2SysBio) Universitat de València-CSIC, Israel Institute for Biological Research,Istanbul University, Istinye University, Jomo Kenyatta University of Agriculture and Technology, Khon Kaen University, Korea Advanced Institute of Science and Technology, KU Leuven, Kyorin University, Laboratoire ERRMECe, Laboratoire M2iSH, Lesaffre International, Louvain University, Masaryk University, Max Planck Institute for Medical Research, Medical center Francesc Macia, MPI, National Taiwan University, North-West Unversity, Pediatric Infectious Diseases Research Center, Phage Consulting, Phage Directory, Pharmabiotic Research Institute (PRI), Polish Academy of Sciences…

Read more

Upcoming Events